118 related articles for article (PubMed ID: 28649984)
1. CD27 expression and its association with clinical outcome in children and adults with pro-B acute lymphoblastic leukemia.
Chen D; Gerasimčik N; Camponeschi A; Tan Y; Wu Q; Brynjolfsson S; Zheng J; Abrahamsson J; Nordlund J; Lönnerholm G; Fogelstrand L; Mårtensson IL
Blood Cancer J; 2017 Jun; 7(6):e575. PubMed ID: 28649984
[No Abstract] [Full Text] [Related]
2. CD44 and CD27 expression pattern in B cell precursor acute lymphoblastic leukemia and its clinical significance.
Kamazani FM; Bahoush GR; Aghaeipour M; Vaeli S; Amirghofran Z
Med Oncol; 2013 Mar; 30(1):359. PubMed ID: 23263849
[TBL] [Abstract][Full Text] [Related]
3. CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia.
Chen D; Camponeschi A; Wu Q; Gerasimcik N; Li H; Shen X; Tan Y; Sjögren H; Nordlund J; Lönnerholm G; Abrahamsson J; Fogelstrand L; Mårtensson IL
Br J Haematol; 2019 Feb; 184(3):418-423. PubMed ID: 30484860
[TBL] [Abstract][Full Text] [Related]
4. High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95.
Troeger A; Glouchkova L; Ackermann B; Escherich G; Meisel R; Hanenberg H; den Boer ML; Pieters R; Janka-Schaub GE; Goebel U; Laws HJ; Dilloo D
Blood; 2008 Aug; 112(4):1028-34. PubMed ID: 18552209
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.
Aref S; Azmy E; El-Bakry K; Ibrahim L; Abdel Aziz S
Pediatr Hematol Oncol; 2017 Aug; 34(5):275-285. PubMed ID: 29144828
[TBL] [Abstract][Full Text] [Related]
6. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
[TBL] [Abstract][Full Text] [Related]
7. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D
Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
Messina M; Chiaretti S; Wang J; Fedullo AL; Peragine N; Gianfelici V; Piciocchi A; Brugnoletti F; Di Giacomo F; Pauselli S; Holmes AB; Puzzolo MC; Ceglie G; Apicella V; Mancini M; Te Kronnie G; Testi AM; Vitale A; Vignetti M; Guarini A; Rabadan R; Foà R
Oncotarget; 2016 Mar; 7(12):13886-901. PubMed ID: 26883104
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia.
Cocco C; Airoldi I
Cytokine Growth Factor Rev; 2011 Jun; 22(3):149-56. PubMed ID: 21764355
[TBL] [Abstract][Full Text] [Related]
10. Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study.
Boer JM; Valsecchi MG; Hormann FM; Antić Ž; Zaliova M; Schwab C; Cazzaniga G; Arfeuille C; Cavé H; Attarbaschi A; Strehl S; Escherich G; Imamura T; Ohki K; Grüber TA; Sutton R; Pastorczak A; Lammens T; Lambert F; Li CK; Carrillo de Santa Pau E; Hoffmann S; Möricke A; Harrison CJ; Den Boer ML; De Lorenzo P; Stam RW; Bergmann AK; Pieters R
Leukemia; 2021 Oct; 35(10):2978-2982. PubMed ID: 34211097
[No Abstract] [Full Text] [Related]
11. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
[TBL] [Abstract][Full Text] [Related]
12. Expression of VEGF and VEGF receptors in childhood precursor B-cell acute lymphoblastic leukemia evaluated by immunohistochemistry.
Diffner E; Gauffin F; Anagnostaki L; Nordgren A; Gustafsson B; Sander B; Gustafsson B; Persson JL
J Pediatr Hematol Oncol; 2009 Sep; 31(9):696-701. PubMed ID: 19707156
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
[TBL] [Abstract][Full Text] [Related]
14.
Hormann FM; Hoogkamer AQ; Beverloo HB; Boeree A; Dingjan I; Wattel MM; Stam RW; Escherich G; Pieters R; den Boer ML; Boer JM
Haematologica; 2019 Oct; 104(10):e455-e459. PubMed ID: 30872366
[No Abstract] [Full Text] [Related]
15. Wntless (GPR177) expression correlates with poor prognosis in B-cell precursor acute lymphoblastic leukemia via Wnt signaling.
Chiou SS; Wang LT; Huang SB; Chai CY; Wang SN; Liao YM; Lin PC; Liu KY; Hsu SH
Carcinogenesis; 2014 Oct; 35(10):2357-64. PubMed ID: 25115440
[TBL] [Abstract][Full Text] [Related]
16. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
[TBL] [Abstract][Full Text] [Related]
17. Relapsed B-acute lymphoblastic leukemia with aberrant myeloperoxidase expression following CAR T-cell therapy: A diagnostic challenge.
Li N; Wang SA; Lin P; Jabbour E; Thompson P; Chen Z; Li S; Xu J; You MJ; Bueso-Ramos CE; Medeiros LJ; Yin CC
Am J Hematol; 2019 Sep; 94(9):1049-1051. PubMed ID: 30916805
[No Abstract] [Full Text] [Related]
18. The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.
Chaber R; Fiszer-Maliszewska L; Noworolska-Sauren D; Kwasnicka J; Wrobel G; Chybicka A
J Pediatr Hematol Oncol; 2013 Apr; 35(3):180-7. PubMed ID: 23511489
[TBL] [Abstract][Full Text] [Related]
19. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance.
Paul MR; Wong V; Aristizabal P; Kuo DJ
J Pediatr Hematol Oncol; 2019 Nov; 41(8):e546-e549. PubMed ID: 30807395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
